Clinical Trial Update: Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 study evaluated the combination of erlotinib hydrochloride and bevacizumab in patients with Stage IV breast cancer; the trial has completed and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Erlotinib hydrochloride (Erlotinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Breast Carcinoma, Stage IV Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-07-24